Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/30/25 16:54 | 7/28/25 | RLAY | Health | BioPrd | Biological Products, (No Diag | Rahmer Peter | MA | O | See rema | 11 | S.m | -1,561 | 5.54 | 0 | -282 | 434 | D | |||||||||||||||
7/30/25 16:54 | 7/28/25 | RLAY | Health | BioPrd | Biological Products, (No Diag | Catinazzo Thomas | MA | O | CFO | 9 | S.m | -690 | 4.81 | 0 | -144 | 379 | D | |||||||||||||||
7/30/25 16:54 | 7/28/25 | RLAY | Health | BioPrd | Biological Products, (No Diag | Bergstrom Donald A | MA | O | P,R,D | 9 | S.m | -626 | 4.14 | 0 | -151 | 616 | D | |||||||||||||||
7/30/25 16:53 | 7/28/25 | RLAY | Health | BioPrd | Biological Products, (No Diag | Adams Brian | MA | O | GC | 9 | S.m | -396 | 4.24 | 0 | -93 | 406 | D | |||||||||||||||
7/10/25 16:55 | 7/9/25 | RLAY | Health | BioPrd | Biological Products, (No Diag | Patel Sanjiv | MA | DO | P,CEO | 6 | S.dm | -4,273 | 4.75 | 0 | -900 | 2,128 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |